News
Reported statistically significant and clinically meaningful improvement in both primary endpoints from the PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trialHazard ratios and improvements in med ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback